The impact of anti-angiogenic agents on cancer therapy
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 129 (11) , 607-620
- https://doi.org/10.1007/s00432-003-0488-9
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- VEGF-Trap: A VEGF blocker with potent antitumor effectsProceedings of the National Academy of Sciences, 2002
- Mechanisms and functions of eph and ephrin signallingNature Reviews Molecular Cell Biology, 2002
- Role of integrins in cell invasion and migrationNature Reviews Cancer, 2002
- Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3The EMBO Journal, 2001
- Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.2001
- Active interaction of human A375 melanoma cells with the lymphatics in vivoHistochemistry and Cell Biology, 2000
- Circulating endothelial precursors: mystery, reality, and promiseJournal of Clinical Investigation, 2000
- Structure, Expression and Receptor-Binding Properties of Novel Vascular Endothelial Growth FactorsPublished by Springer Nature ,1999
- Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4Cell, 1998
- Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.Proceedings of the National Academy of Sciences, 1996